Vanda Pharmaceuticals (VNDA) Tops Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.57 -4.79%
Revenue Growth %: +17.5%
Financial Fact:
Product sales: 38.48M
Today's EPS Names:
SFNC, CSBR, MAN, More
Revenue Growth %: +17.5%
Financial Fact:
Product sales: 38.48M
Today's EPS Names:
SFNC, CSBR, MAN, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q2 EPS of ($0.11), $0.12 better than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ManpowerGroup (MAN) Tops Q2 EPS by 4c; offers guidance
- UnitedHealth shares surge on strong earnings beat and guidance
- Abbott beats second-quarter estimates, raises 2026 guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
